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Abstract: A delicate balance of reactive oxygen species (ROS) exists inside the cell: when the
mechanisms that control the level of ROS fail, the cell is in an oxidative stress state, a condition
that can accelerate aging processes. To contrast the pro-aging effect of ROS, the supplementation
of antioxidants has been recently proposed. Sulforaphane (SFN) is an isothiocyanate isolated from
Brassica plants that has been shown to modulate many critical factors inside the cells helping to
counteract aging processes. In the present work, we exposed human dermal fibroblast to short,
sublethal and repeated treatments with hydrogen peroxide for eight days, without or in combination
with low concentration of SFN. Hydrogen peroxide treatments did not affect the oxidative status of
the cells, without any significant change of the intracellular ROS levels or the number of mitochondria
or thiols in total proteins. However, our regime promoted cell cycle progression and cell viability,
increased the anti-apoptotic factor survivin and increased DNA damage, measured as number of foci
positive for γ-H2AX. On the other hand, the treatment with SFN alone seemed to exert a protective
effect, increasing the level of p53, which can block the expansion of possible DNA damaged cells.
However, continued exposure to SFN at this concentration could not protect the cells from stress
induced by hydrogen peroxide.
Keywords: oxidative stress; sulforaphane; fibrobalsts; p53
1. Introduction
Senescence is a complex process where the integrity and the structure of the nuclear scaffold
changes [1]. One important factor contributing to cell senescence is oxidative stress [2].
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Reactive oxygen species (ROS) are physiological by-products of mitochondria metabolism.
Oxidative stress is due to an unbalanced oxidant/antioxidant status occurring in cells that could
cause oxidative damage to DNA, lipids and proteins. ROS level regulates physiological functions,
including signal transduction, gene expression, and proliferation, therefore they underlie physiological
and pathological events [3]. For example, mitochondrial ROS may activate an adaptive response that
promotes health to extend the lifespan through diseases prevention [4]. ROS overproduction, on the
other hand, hampers nuclear and mitochondrial DNA repair at multiple steps, contributing to cell
genomic instability [5]. Interestingly, ROS, including hydrogen peroxide, can inhibit cell growth and
induce cell death and senescence in a context-dependent manner [6]. Accordingly, a recent paper
reports that low levels of ROS can improve the defense mechanisms by inducing adaptive responses,
which in turn contribute to stress resistance and longevity [7]. In contrast, high levels of ROS induce
ineffective adaptive responses, contributing to aging onset and progression [7]. Many anti-aging
strategies, from the scavenger of free radicals to the enhancing of antioxidant factors, are proposed to
buffer the level of ROS.
The main goal of the present study was to investigate the impact of short and repeated sublethal
treatments with hydrogen peroxide, commonly used to mimic oxidative stress [2], alone or in
combination with sulforaphane (SFN) on human primary dermal fibroblasts (hSDF) focusing on
critical biological functions of the cells. Recent evidence in fibroblasts shows that concentrations
of 90–360 µM of hydrogen peroxide are sufficient to induce oxidative stress and premature cellular
senescence in vitro recapitulating an aging process profile [8]. However, the possible protective effect
of factors such as SFN on normal human cells such as human fibroblasts is not investigated in the
literature yet. This kind of study appears crucial to plan possible advice in general for anti-aging
purposes. We were not in fact strictly interested in skin aging but in general to develop a strategy
to investigate the impact of specific factors on critical cellular functions linked to aging such as
DNA damage.
SFN is a well tolerated natural compound obtained from cruciferous vegetables, which has been
shown to have a cytoprotective effect through Nrf2-mediated induction of phase 2 detoxification
and anti-oxidant enzymes, such as heme oxygenase-1 (HO-1), NAD[P] H:quinone oxidoreductase-1
(NQO1), superoxide dismutase (SOD), glutathione S-transferase (GST), and γ-glutamyl cysteine ligase
(γ-GCL), which elevate cell defense against oxidative damage and promote the removal of potential
carcinogens [9]. However, it is becoming clear that multiple mechanisms are activated in response
to SFN, including the suppression of cytochrome P450 enzymes, the induction of apoptotic pathways,
the suppression of cell cycle progression, and the inhibition of angiogenesis and anti-inflammatory
activity [9–11]. Another important biological activity of SFN is the negative control of HDAC
activity [9].
Altogether, our findings show that prolonged exposure to SFN alone increases p53 expression,
suggesting that, in the absence of exogenous oxidative stress stimuli, it plays a protective role against
DNA damage. The main significance and consequence of this findings is that everyday life can lead
to a short and low increase of hydrogen peroxide repeated in time and SFN is not able to contrast
these effects but exerts an anti-aging effect without oxidative stress changes. It is tempting to speculate
that the combination of many factors rather than a single element can have a better protective effect.
Further investigations will try to address these points.
2. Material and Methods
2.1. Cell Lines and Treatments
Human primary dermal fibroblasts (hSDF) (BS PRC 41, IZSLER, Brescia, Italy) were established
from a skin biopsy obtained from a healthy adult donor during a surgical procedure [12] and cultured
in EMEM (Euroclone) containing 1% L-Glutamine, 1% Penicillin/Streptomycin and 10% FBS (basal
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medium) at 37 ◦C in 5% CO2 for no more than 10 passages [12]. The cells were treated with sublethal
concentration of H2O2, for short (30 min) and repeated time [2].
Briefly, subconfluent cells were plated and exposed to 15 or 25 µM H2O2 (Fluka cod.95302) for
30 min at 37 ◦C. This treatment was repeated every 48 h for four times (Figure S1). Untreated cells were
plated and grown in basal medium for the entire duration of the experiment (eight days) (Figure S1).
After every treatment with H2O2, the cells were washed twice with sterile PBS and maintained in basal
medium until the next treatment. Subconfluent cells were treated with sulforaphane (SFN, cod.S4441,
Sigma) at a final concentration of 1 µM for eight days after plating (see Figure S1). In combined
experiments with H2O2 and SFN, cells were maintained in basal medium containing H2O2 for 30 min
without SFN, and then replaced with fresh medium containing SFN (Figure S1).
2.2. Proliferation Assay
Sulforhodamine B (SRB) assay allows quantifying cellular protein content [13]. Briefly, the cells
were fixed with 10% trichloroacetic acid (Sigma, cod.T6399) for 2 h at 4 ◦C and 0.04% (wt/vol) SRB
protein-bound dye (Sulforhodamine B Sigma, cod. S1402, dissolved in 10 mMTris base solution) was
added to each well and incubated at RT for 1 h. After four washes with 1% (vol/vol) acetic acid, the
samples were left to air-dry at room temperature. Then, 100 µL of 10 mM Tris base solution (pH 10.5)
was added to each well and the plate was shaken on an orbital shaker for 10 min to solubilize the
protein-bound dye. The absorbance at 510 nm was detected using an microplate reader (BioRad).
2.3. Cell Cycle Analysis
Subconfluent cells were harvested by trypsinization, pelleted and fixed in 70% cold ethanol
and subsequently stained with propidium iodide (PI, cod. P4864, Sigma) for 30 min at
4 ◦C [14]. PI fluorescence was analyzed using FACS Vantage SE Becton Dickinson flow cytometry.
The percentages of cells in each phase of the cell cycle were calculated using FlowJO software.
2.4. p53 Level of Expression by Flow Cytometry
Subconfluent cells were fixed for 15 min in ice-cold methanol at −20 ◦C, and incubated with
primary antibody p53 linked to FITC at 4 ◦C under dark condition (1:500, Abcam, ab156030) for 1 h
and then immediately analyzed using FACS Vantage SE Becton Dickinson flow cytometry. Analysis
were conducted using FlowJo software and the expression of p53 for each sample is reported as the
ratio of the intensity of fluorescence with respect to unstained cells due to autofluorescence.
2.5. Quantification of Intracellular ROS by H2DCFDA
To detect ROS in cells, the cell-permeant 2’,7’-dichlorodihydrofluorescein diacetate (H2DCFDA)
(Thermo Fisher, cod.D399) was used. It was converted into the highly fluorescent
2’,7’-dichlorofluorescein (DCF) by the cleavage of acetate groups due to intracellular esterases and
oxidation. Briefly, acetylated dye was reconstituted in anhydrous dimethylsulfoxide (DMSO) at stock
concentration of 100 µM just prior to use. Cells were incubated in 10 µM dye solution in pre-warmed
PBS containing calcium and magnesium for 1 h at 37 ◦C in 5% CO2, protected from light. Then, the
loading buffer was removed and cells were returned to pre-warmed growth medium and incubated at
the optimal temperature, for 1 h at 37 ◦C in 5% CO2 to allow esterases to hydrolyze the acetate groups
and render the dye responsive to oxidation. Fluorescence was determined using Ensight microplate
fluorescence reader (Perkin Elmer) using Ex/Em: 492–495/517–527 nm. Results are reported as mean
fluoresce values for each sample.
2.6. Quantification of Numbers of Mitochondria
To quantify the numbers of mitochondria per cell, MitoTracker probe was used. The MitoTracker
probe passively diffuses across the plasma membrane and accumulates in active mitochondria.
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Lyophilized MitoTracker (Thermo Fisher, cod. M7512) was reconstituted in anhydrous
dimethylsulfoxide (DMSO) to a final concentration of 1 mM, and then the cells were incubated
in 250 nM MitoTracher probe solution in pre-warmed growth medium for 45 min at 37 ◦C in 5% CO2
under dark condition. Fluorescence was detected using FACS Vantage SE Becton Dickinson flow
cytometry and the data were analyzed by FlowJo software. Results are reported as the ratio of the
intensity of fluorescence of each sample with respect to unstained cells due to autofluorescence.
2.7. Quantification of Thiols in Proteins
Total cellular proteins were obtained by cell lysis with ice-cold lysis buffer (50 mM Tris-HCl, pH 7.4,
150 mM NaCl, 1% TRITON X-100, 0.1% SDS, 0.5% sodium deoxycholate supplemented with protease
inhibitors). The lysate was incubated on ice for 30 min and centrifuged at 10,000 rpm for 10 min at 4 ◦C
to remove cell debris. The concentration of protein was assessed using BCA protein assay. To detect
thiols present in proteins, a biotin-maleimide assay was carried out. Briefly, 40 mM biotin-maleimide
stock solution was prepared in DMSO and stored at −20 ◦C. Then, 1 mg/mL of protein was incubated
with 75 µM biotin-maleimide solution for 1 h at RT and mixed to Laemmli sample buffer (2% SDS,
20% glycerol, and 125 mM Tris-HCl, pH 6.8), boiled for 5 min at 90 ◦C and immediately loaded on
12% SDS-PAGE gel [15]. The proteins were then electroblotted onto a low-fluorescence polyvinylidene
difluoride (LF-PVDF) membrane. Biotin tag was revealed using streptavidin-HRP assay as following.
LF-PVDF membrane was washed with PBST (10 mM Na-phosphate, pH 7.2, 0.9% (w/v) NaCl, 0.1%
(v/v) Tween-20 (Sigma Aldrich, cod. P9416) [15] and blocked for 1 h in 5% (w/v) non-fat dry milk
in PBST. After washing three times with PBST for 5 min, biotin tag was probed by 2-h incubation
with 5% non-fat dry milk/PBST containing streptavidin-HRP (1:5000 dilution, BioRad). Biotinylated
proteins were visualized by ECL detection (cod.1705061, Biorad) using Chemidoc Touch Imaging
System (Biorad). ECL signals were normalized with respect to PVDF stain free [16].
2.8. Western Blot
Subconfluent cells were lysed in Laemmli sample buffer (2% SDS, 20% glycerol, and 125 mM
Tris-HCl, pH 6.8), briefly centrifuged and the protein concentration of the supernatant was measured
by BCA Protein Assay Kit (cod.23225, Thermo Scientific). Then 15 µg protein were loaded on
12% SDS-PAGE gel and transferred on PVDF using the TranBlot Turbo Transfer System Bio-Rad
(cod.1704150, BioRad). After incubation of the PVDF sheet with 5% fat dry milk (cod.70166, Sigma) in
PBS Tween 0.1% for 1 h at room temperature, the membrane was incubated overnight at 4 ◦C with
primary antibody, anti-Nrf2 (1:2000, ADI-KAP-TF125, ENZO). As housekeeping gene, anti-βactin
(1:10,000, ab11003, Abcam) was used. The sheet was then incubated with secondary antibodies,
anti-rabbit HRP (Bio-Rad 1: 3000) or anti-Mouse HRP (Bio-Rad 1: 3000) for 1 h. ECL Blotting reagents
(GE Healthcare, cod. RPN2109) were used at room temperature to detect chemioluminescence. The
signal was acquired using Chemidoc Touch (cod. 1708370, Bio-Rad). Densitometric analysis was
carried out with ImageJ.
2.9. Immunofluorescence
Subconfluent cells plated on coverslips were fixed with 3.7% paraformaldehyde (BDH 29447)
or in 100% cold methanol. For paraformaldehyde fixed cells, the cells were permeabilized with
0.1 %TritonX-100 in PBS for 15 min at RT and then incubated with blocking solution (1%BSA/10%
goat-serum/0.3 M glycine/0.1% Tween in PBS) for 1 h at RT. The cells were incubated overnight at
4 ◦C with the primary antibody as following: γ-H2AX (1:700, Abcam, ab2893-Phospho139, Rabbit)
or anti-survivin (1:250, NB500-201, Novus Biological, Rabbit). The samples were incubated with
secondary antibodies FITC anti-Rabbit (1:250, ab150077, AbCam) for 1 h at RT and then mounted with
Pro-long anti-fade reagent (P7481, Life Technologies) with DAPI to stain the nuclei. The images were
acquired with a Leica TCS NT confocal microscope.
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2.10. γ-H2AX Spots Counting and Nuclear Survivin
γ-H2AX spots inside the nuclei were counted using spot detector tool of ICY Software as described
in our previous paper [17]. Briefly, we created a ROI for each nucleus and we computed the number of
the marker spots inside its enabling the Scale n.3 with a sensitivity equal to 15. We also extracted the
number of nuclei from the images to calculate the ratio of the number of foci per nucleus. The level
of expression of survivin fluorescence inside the nucleus was evaluated using a custom pipeline in
ICY software. Briefly, we created a ROI for each nucleus and evaluated the mean intensity of Survivin
signal over all the nuclear surface. DAPI channel intensity was considered to verify the absence
possible bias due to differences between the nuclei and images.
2.11. Statistical Analysis
Statistical significance analyses were performed using the Kolmogorov–Smirnov test and
unpaired t-test.
3. Results
3.1. Effect of Short and Repeated Sublethal Treatment with Hydrogen Peroxide without or in Combination with
SFN on the Oxidative Status of hSDF
H2DCFDA is a chemically reduced form of fluorescein used as an indicator for intracellular
ROS levels. The short oxidizing treatment (30 min) repeated every 48 h for eight days with sublethal
concentrations (15 µM or 25 µM) of hydrogen peroxide (see Figure S1) according to Caldini et al. [2]
alone or in combination with 1 µM SFN does not affect the levels of ROS measured using H2CDFDA
assay or the numbers of mitochondria in the cells quantified by flow cytometry (Figure 1). These
data suggest that, during the 48 h of recovering, hSDF cells implemented response and adaptive
mechanisms to protect against permanent injuries. Since it is known that Nfr2 is a transcription factor
whose activation is induced by SNF [18,19], we performed Western blot of Nrf2 on untreated cells with
respect to cells treated with SFN for 8days. As shown in Figure S2, we found a significative increase in
the level of Nrf2 in treated cells (p < 0.01). Furthermore, we also checked the ability of these cells to
be affected by high levels of ROS using H2DCFDA reduction as an indicator of the intracellular ROS
level, as shown in Figure 1. The treatment with 500 µM hydrogen peroxide for 1 h doubled the level of
ROS (p < 0.0001), confirming that the cells responded to hydrogen peroxide induction.
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Figure 1. Evaluation of oxidative status after treatment with sublethal concentration and repeated
exposure with hydrogen peroxide without or with 1 µM SFN. (a) ROS level Subconfluent cells treated as
described in Figure S1 and Material and Methods Section with 15 or 25 µM hydrogen peroxide (15 or 25)
without or with 1 µM SFN (15+SFN, or 25+SFN, respectively) up to eight days and incubated in 10 µM
H2DCFDA (Thermo Fisher, cod.D399) in pre-warmed PBS for 1 h at 37 ◦C in 5% CO2. Cells were also
treated with 500 µM hydrogen peroxide for 1 h and then the fluorescence was immediately quantified
(positive control). Fluorescence was determined using Ensight microplate fluorescence reader (Perkin
Elmer) using Ex/Em: 492–495/517–527 nm. Results are reported as mean fluoresce values for each
sample. Each bar represents the mean and the corresponding error bars of 16 independent measures
for all the treatments and untreated cells with the exception of 500 µM hydrogen peroxide where
we carried out four independent measurements. a: p < 0.0001 versus untreated cells. (b) Numbers
of Mitochondria: Cells treated as described in (a) were quantified using MitoTracker probe, which
passively diffuses across the plasma membrane and accumulates in active mitochondria. Subconfluent
cells were incubated with 250 nM MitoTracker (Thermo Fisher, cod. M7512) for 45 min at 37 ◦C in 5%
CO2. Fluorescence was detected using FACS Vantage SE Becton Dickinson flow cytometry and the
data were analyzed by FlowJo. Results are reported as the ratio between the intensity of fluorescence
of each sample with respect to unstained cells due to autofluorescence. The bars are the mean with
the statistic errors of three independent experiments. (c) Levels of thiols into total protein. Total
cellular proteins were obtained by cell homogenization with ice-cold lysis buffer. The lysate was
incubated on ice for 30 min and centrifuged at 10,000 rpm for 10 min at 4 ◦C to remove cell debris.
The concentration of protein was assessed using BCA protein assay. To detect thiols present into
proteins a biotin-maleimide assay was carried out. First, 1 mg/mL of protein was incubated with
75 µM biotin-maleimide solution for 1 h at RT and then mixed to Laemmli sample buffer, boiled for
5 min at 90 ◦C and immediately loaded on 12% SDSPAGE gel. The proteins were then electroblotted
onto a low-fluorescence polyvinylidene difluoride (LF-PVDF) membrane. Biotin tag was revealed
using streptavidin-HRP assay. Biotinylated proteins were visualized by ECL detection (cod.1705061,
Biorad) using Chemidoc Touch Imaging System (Biorad). ECL signals were normalized with respect to
PVDF stain free. This gel is representative of four independent experiments carried out.
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It is known that oxidative stress leads to the formation of unwanted disulfide bonds in the
cytoplasm, eventually leading to impaired protein function. To face this, the cells have several
mechanisms to increase the intracellular levels of thiols [20]. Notably, intracellular increase of thiol
levels are strongly associated with an increased tolerance to an oxidant stress [20] since they act as
extraordinarily efficient antioxidants protecting the cells against consequences of damage induced
by ROS [21]. Differently, an age-dependent reduction in the amount of (free) thiols occurs in plasma
proteins in healthy humans. This indicates that the efficiency of the reduced protein thiol pool as
an antioxidant defense system decreases with age. The drop in the plasma level of protein thiol
suggests depletion and/or impairment of the antioxidant capacity of plasma [22]. Indeed, the protein
thiolation index, i.e., the molar ratio between the sum of all low molecular mass thiols bound to plasma
proteins (forming, as a whole, S-thiolated proteins) and protein free thiols, is a suitable biomarker
of oxidative stress [23]. Protein thiolation index shows a near linear age-dependent increase during
aging in humans and is a useful indicator of thiol-specific oxidative stress in patients with end stage
renal disease on maintenance hemodialysis [24]. Under our experimental conditions, the levels of
reduced thiols in total proteins measured by biotin maleimide assay did not show any significant
change (Figure 1).
3.2. SFN and Oxidative Stress Decrease Cell Vitality and Regulate Apoptosis
The short treatment (30 min) with H2O2 repeated every 48 h for eight days with sublethal
concentrations (15 µM or 25 µM) (Figure S1) impacted cell cycle profile of hSDF cells, as shown in
Figure 2a. In fact, we observed a shift of distribution towards S-phase in all experimental conditions
and a slight increase in the number of cells into G2-M phase when treated with hydrogen peroxide
combined with SFN (Figure 2a). On the other hand, the treatment with alone SFN did no result in
restoring the typical cell cycle pattern distribution of these cells and in combination with hydrogen
peroxide does not protect from the effect due to oxidative stress (Figure 2a). Since the cells were not
synchronized, it is tempting to speculate that the number of cells that are in a certain cell cycle phase is
proportional to the time that cells spend in that phase of the cell cycle. We also detected the viability
of the cells with the SRB assay. As shown in Figure 2b, hSDFs viability decreased significantly with
25 µM of H2O2 alone. The cytotoxic effect of 25 µM of H2O2 was not prevented by the presence of SFN
(Figure 2b).
To investigate whether this regime changed the apoptotic pathway, we analyzed the expression of
a well known anti-apoptotic factor, survivin. Figures 2c and S3 show an increased level of expression
of survivin in hSDF cells treated with both concentrations of hydrogen peroxide in the absence
and presence of SFN. Moreover, the treatment with SFN alone did not affect survivin expression
(Figures 2c and S3). We also checked the presence in the medium of apoptotic cells every 48 h when
we changed the medium of the cells with fresh one after hydrogen peroxide treatment. We found
always less than 4% of apoptosis.
Finally, we checked p53 expression, a well known protein that controls the genome by
orchestrating a variety of DNA-damage responses to restore genome stability and that plays a critical
role in triggering apoptotic pathways in damaged cells [25]. Interestingly, the treatment with 1 µM SFN
alone increased significantly the level of expression of total p53 (Figure 2d). This effect disappeared
when the cells were exposed to both SFN and hydrogen peroxide (Figure 2d).
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Figure 2. Effect on cell vitality, PI staining and Survivin expression of sublethal concentration and
repeated exposure to hydrogen peroxide without or with 1 µM SFN. The subconfluent treated cells as
described in Figure S1 and Material and Methods Section with 15 or 25 µM hydrogen peroxide (15 or 25)
without or with 1 µM SFN (15+SFN, or 25+SFN, respectively) up to eight days. (a) Propidium Iodide (PI)
staining: Subconfluent cells were fixed in 70% cold ethanol and stained with PI (cod. P4864, Sigma) for
30 min at 4 ◦C. PI fluorescence was analyzed using FACS Vantage SE Becton Dickinson flow cytometry.
The percentages of cells in each phase of the cell cycle were calculated using FlowJo software.The
bars show the mean and the statistic errors of two independent experiments. (b) Proliferation assay:
Sulforhodamine B (SRB) assay allowed quantifying cellular protein content. Briefly, cells were fixed
with 10% Trichloroacetic acid (Sigma, cod.T6399) for 2 h at 4 ◦C. 0.04% (wt/vol) SRB protein-bound
dye was added to each well and incubated at RT for 1 h. Then, 100 µL of 10 mM Tris base solution
(pH 10.5) was added to each well and the plate placed on an orbital shaker for 10 min to solubilize
the protein-bound dye. Absorbance was detected using a Ensight microplate reader (Perkin Elmer) at
510 nm. The bars are the mean and statistic errors of at least 18 independent sample. **** p < 0.0001
versus untreated cells. (c) Immunofluorescence of Survivin. Subconfuent cells plated on coverslips
were fixed with 3.7% paraformaldehyde, permeabilized with 0.1%TRITOX-100 in PBS for 15 min at
RT, and incubated overnight at 4 ◦C with anti-Survivin (1:250, NB500-201, Novus Biological). The
samples were incubated with the secondary antibody FITC anti-Rabbit (1:250, ab150077, AbCam) and
then mounted with Pro-long anti-fade reagent (P7481, Life Technologies) with DAPI to stain the nuclei.
The images were acquired with a Leica TCS NT confocal microscope. Here is shown the quantification
of the nuclear fluorescence (see Materials and Methods). In the bars are reported the number of cells
analyzed for each conditions of at least two independent experiments. (d) p53 level of expression by
flow cytometry: Subconfluent cells were fixed for 15 min in ice cold methanol at −20 ◦C, and then
incubated with primary antibody anti-p53 FITC-conjugated at 4 ◦C (1:500, Abcam, ab156030 Mouse) for
1 h and then immediately analyzed using FACS Vantage SE Becton Dickinson flow cytometry. Analysis
were conducted using FlowJo software and the expression of p53 for each sample is reported as the
ratio between the intensity of fluorescence with respect to unstained cells due to autofluorescence.
Two independent experiments were carried out, each in triplicate.
Int. J. Environ. Res. Public Health 2019, 16, 657 9 of 13
3.3. Effect of SFN Alone or with Hydrogen Peroxide on DNA Damage
Histone γ-H2AX is the most sensitive marker of double-stranded DNA breaks (DSB) and telomere
shortening [26]. Herein, we quantified the number of γ-H2AX foci in hSDF cells after eight days of
hydrogen peroxide treatment with or without 1 µM SFN. As shown in Figure 3, there was a significant
increase in the number of γ-H2AX positive foci, increasing the concentration of hydrogen peroxide.
In SFN treated hSDF cells, there was no significant change in comparison to the untreated cells
(Figure 3).
a) b) d)
f)
a)
c d
b)
b
Figure 3. Effects of SFN alone or in combination with hydrogen peroxide on DNA-damage
Subconfluent cells were treated as described in Figure S1 and Material and Methods Section. (a) An
example of immunofluorescence obtained with cells untreated (CTRL) and treated with 25 µM
hydrogen peroxide in presence or absence of SFN. Scale bar is 10 µM. Untreated cells (a,b); and
treated ones (c,d) stained for γH2AX (1:700, Abcam, ab2893-Phospho139) (a,c) or both for γH2AX and
DAPI (b,d). Cells were fixed with 3.7% paraformaldehyde, permeabilized with 0.1%TRITOX-100 in PBS
for 15 min at RT and incubated overnight at 4 ◦C with the γH2AX (1:700, Abcam, ab2893-Phospho139).
The samples were then incubated with FITC anti-Rabbit (1:250, ab150077, AbCam) for 1 h at RT and
mounted with Pro-long anti-fade reagent (P7481, Life Technologies) with DAPI to stain the nuclei.
The images were acquired with a Leica TCS NT confocal microscope. Panel b shows γH2AX spots
inside the nuclei counted using spot detector tool of ICY Software as described in the Materials and
Method section. All the resulting values are normalized with the total number of pixels of their image,
to make possible the comparison of all the nuclei, one with each other. In the bars are reported the
number of cells analyzed for each conditions. **** p < 0.0001 versus untreated cells; b: p < 0.0001 versus
SFN treated cells.
4. Discussion
Sulforaphane (SFN) is mainly present in Cruciferae such as broccoli sprouts and cabbages. It is a
very well tolerated factor, showing antioxidant properties and inhibiting histone deacetylase enzymes
(HDAC) [9].
SFN seems to have a double-faced effect: on the one hand, it helps the clearance of progerin
in accelerating aging [27], and, on the other hand, it acts as anti-tumorigenic factor targeting cancer
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stem cells (CSC) [10,28]. Furthermore, high levels of SFN (higher than 5 µM) were shown to induce
apoptosis in cancer cells increasing ROS [11]. However, very little is known about the effects of SFN on
healthy human cells. In a recent study, the effect of SFN on human mesenchymal stem cells (MSCs) at
different concentrations has been investigated [29], resulting in contrasting effects. In fact, while low
(1 µM) doses of SFN for three days enhanced the cellular proliferation and protected the cells against
apoptosis and senescence, higher (5 µM) concentrations had a cytotoxic effect, leading to cell cycle
arrest, programmed cell death and senescence [29]. Some ROS, mainly hydrogen peroxide, at sublethal
concentrations act as second messenger in signaling cascades and are involved in cell proliferation
and differentiation [30,31]. It has been recently reported that moderate increases in ROS levels trigger
signaling pathways involved in cell proliferation, whereas an excessive ROS increase causes oxidative
stress, which in turn induces cell death and/or senescence [32].
The main goal of this study was to investigate the combined effect of sublethal concentrations
and long-term exposure to SFN and H2O2 on human primary normal dermal fibroblasts (hSDF) on
critical cell functions and the possible protective role of SFN against negative effects of oxidative
stress. Regarding to hydrogen peroxide, we used a physiological concentration [33]. Our experimental
approach led to faithfully mimicking physiologic stress conditions. In fact, in the majority of the
studies present in the literature, the experimental induction of oxidative stress is achieved by short
exposure of the cells to high concentration of exogenous ROS, or by long term and continuous exposure
to moderate concentration of exogenous ROS. Both models are unlikely to reproduce physiologic
conditions, where stimuli are discontinuous and ROS exposure limited. Indeed, excluding particular
pathological conditions, it is very rare to find constantly increased level of ROS in healthy people but
rather occasional and short ROS levels increases, albeit for a long time [34]. The sublethal exposure to
hydrogen peroxide repeated for 30 min every 48 h up to eight days does not significantly change the
oxidative status of the cell measured as levels of ROS, number of mitochondria and levels of thiols
in total proteins. This suggests that, using our protocol, the cells are able to activate compensatory
mechanisms and recover the physiological oxidative status. However, hydrogen peroxide, both alone
or in combination with SFN, modifies the complex and delicate physiology of the cells since it promotes
the cell cycle, contrasts apoptosis increasing Survivin expression albeit without changing p53 levels.
Moreover, hydrogen peroxide exposure results in a higher number of γ-H2AX positive foci, which
quantified DNA damage.
Two interesting results are related to SFN. Firstly, SFN induces alone an increase of p53 but does
not induce any DNA damages. Consistently, the presence of SFN upregulates and stabilizes p53
oscillatory physiologic behavior probably due to its indirect effect on NRF2 and HIPK2 [35–37]. In fact,
SNF decreases the ubiquitinization of Nrf2 [38], which leads to Nrf2 to translocate into the nucleus
where it can accumulate and activate its target genes [37]. In particular, HIPK2 is transcriptionally
regulated by Nrf2 [35] and its overexpression downregulates WIP1 participating to a negative feedback
loop with p53 [39,40]. A direct consequence is an increase of p53 level and a stabilization of its
oscillatory dynamics [36,40,41]. Moreover, in our experimental conditions, the presence of hydrogen
peroxide stimulus prevent the SFN-induced increase of p53 possibly due to the activation of different
response pathways p53 independent.
The second interesting result is that SFN cannot counteract the effect of hydrogen peroxide in
hSDFs, confirming SFN negligible scavenging capacity [42] but also suggesting the presence of a
common mechanism of action that results in cell type-specific response of either cell death and survival.
In non-cancer cells, which have an inherent ROS level (IRL) lower than for cancer cells, SFN exposure
causes just an adaptive antioxidant response, whereas, in cancer cells, which have an IRL closer to the
ROS death threshold, leads to growth inhibition and death [42]. In conclusion, our findings show that
SFN is not able to protect against low concentration and repeated exposure to hydrogen peroxide in
human fibroblasts cells resembling a physiological condition of everyday life. Further studies should
investigate the possible effect of synergic factors to protect these kinds of cellular damages. In fact, to
Int. J. Environ. Res. Public Health 2019, 16, 657 11 of 13
untangle the complex network inside the cells, it is necessary to investigate the co-exposure to multiple
factors in a model such as ours that resembles a physiological condition.
Supplementary Materials: The following are available at http://www.mdpi.com/1660-4601/16/4/657/s1.
Figure S1: Schematic time line of the treatments with hydrogen peroxide alone or in combination with SFN,
Figure S2: Level of expression of Nrf2 in SFN treated cells, Figure S3: Immunoflorescence of survivin.
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